Germany is at the greatest commercial risk from Washington’s onshoring policies that may trigger tariff and non-tariff measures, warns the data and analytics firm.
The agreement will support scaled production of QCellS’s hiPSC-based dermal papilla cell-culture media using Medipost’s manufacturing and quality control capabilities.
